BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-10.66%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$551M
AUM Growth
–
Cap. Flow
+$551M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
31.05%
Holding
130
New
130
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$21.4M |
| 2 |
CELG
Celgene Corp
CELG
|
$21.1M |
| 3 |
Medtronic
MDT
|
$20.7M |
| 4 |
Biogen
BIIB
|
$19.9M |
| 5 |
Abbott
ABT
|
$16M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 93% |
| 2 | Financials | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Globus Medical
GMED
$8.27B
| $2.08M | 0.38% | +87,700 | New | +$2.08M |
|
|
QGENF
77
DELISTED
QIAGEN NV
QGENF
| $2.04M | 0.37% | +91,500 | New | +$2.04M |
|
|
ZLTQ
78
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $2.04M | 0.37% | +75,000 | New | +$2.04M |
|
|
LCI
79
DELISTED
Lannett Company, Inc.
LCI
| $1.93M | 0.35% | +107,810 | New | +$1.93M |
|
80
AngioDynamics
ANGO
$417M
| $1.86M | 0.34% | +151,400 | New | +$1.86M |
|
81
Healthcare Services Group
HCSG
$1.13B
| $1.84M | 0.33% | +50,000 | New | +$1.84M |
|
|
ICPT
82
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.73M | 0.31% | +13,500 | New | +$1.73M |
|
83
Novavax
NVAX
$1.21B
| $1.68M | 0.3% | +325,000 | New | +$1.68M |
|
84
Teleflex
TFX
$5.59B
| $1.57M | 0.29% | +10,010 | New | +$1.57M |
|
85
MacroGenics
MGNX
$112M
| $1.56M | 0.28% | +83,000 | New | +$1.56M |
|
86
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.51M | 0.27% | +24,000 | New | +$1.51M |
|
87
DaVita
DVA
$9.85B
| $1.47M | 0.27% | +20,000 | New | +$1.47M |
|
|
JUNO
88
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.41M | 0.26% | +37,000 | New | +$1.41M |
|
89
DexCom
DXCM
$29.5B
| $1.36M | 0.25% | +20,000 | New | +$1.36M |
|
90
Prothena Corp
PRTA
$441M
| $1.28M | 0.23% | +31,000 | New | +$1.28M |
|
91
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.26M | 0.23% | +45,000 | New | +$1.26M |
|
|
RDUS
92
DELISTED
Radius Health, Inc.
RDUS
| $1.26M | 0.23% | +40,000 | New | +$1.26M |
|
|
BLUE
93
DELISTED
bluebird bio
BLUE
| $1.23M | 0.22% | +29,000 | New | +$1.23M |
|
94
Labcorp
LH
$23.1B
| $1.17M | 0.21% | +10,000 | New | +$1.17M |
|
|
WMGI
95
DELISTED
Wright Medical Group Inc
WMGI
| $1.17M | 0.21% | +70,309 | New | +$1.17M |
|
|
CLVS
96
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.01M | 0.18% | +52,500 | New | +$1.01M |
|
|
QTNT
97
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $880K | 0.16% | +100,000 | New | +$880K |
|
98
AbbVie
ABBV
$372B
| $857K | 0.16% | +15,000 | New | +$857K |
|
|
INFI
99
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $843K | 0.15% | +160,000 | New | +$843K |
|
|
ALDR
100
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $808K | 0.15% | +33,000 | New | +$808K |
|